M. Rogers

Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides

B.A. Tjoa, S.J. Simmons, Victoria Bowes et al. · The Prostate · 1998 · 243 citations

Medicine, Immunology, Oncology +17

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

G.P. Murphy, B.A. Tjoa, S.J. Simmons et al. · The Prostate · 1999 · 240 citations

Medicine, Immunology, Oncology +17

Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment

G.P. Murphy, B.A. Tjoa, S.J. Simmons et al. · The Prostate · 1999 · 186 citations

Medicine, Immunology, Oncology +17

Follow-up evaluation of a phase II prostate cancer vaccine trial

B.A. Tjoa, S.J. Simmons, A. Elgamal et al. · The Prostate · 1999 · 147 citations

Medicine, Immunology, Oncology +17

Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)

Michael L. Salgaller, Patricia A. Lodge, Joanne G. McLean et al. · The Prostate · 1998 · 119 citations

Life Sciences, Immunology, Oncology +17